|
Market Closed -
Nasdaq
07:00:00 31/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.7119 USD | -1.68% |
|
-4.53% | -37.55% |
| 26/10 | Top Premarket Gainers | MT |
| 12/10 | Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use | MT |
Evolution of the Average Target: IRIDEX Corporation
Evolution of the Target Price: IRIDEX Corporation
Changes in Analyst Recommendations: IRIDEX Corporation
93ff4ba9aa2fbbb59611.U5_mxGbiiTvUCw8CrE_hVp3pIq8GsTJVMZJkY4JedWk.NdqfoACV60GkXEFo_Q6HH9K9Rpx24WUmU6ozCfg3LA496tbzLJvcAqJ4fA~593d90f79920a315ea3eeecb8d8ce76f


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7119USD
Average target price
2.750USD
Spread / Average Target
+286.29%
High Price Target
2.750USD
Spread / Highest target
+286.29%
Low Price Target
2.750USD
Spread / Lowest Target
+286.29%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- IRIX Stock
- Consensus IRIDEX Corporation
Select your edition
All financial news and data tailored to specific country editions
















